Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J Biol Chem 1974; 249(16): 5153-62. PMID:4368448

Bayley GR, Lipids and disorders of lipoprotein metabolism. The LDL receptor. Clinical biochemistry: metabolic and clinical aspects (3rd edition). Churchill Livingstone 2014, pp 702-36.

Cuchel M, Raal FJ, Hegele RA, et al. 2023 Update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J 2023;44(25): 2277-91. https://doi.org/10.1093/eurheartj/ehad197

France M, Rees A, Datta D, et al. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis 2016;255:128–39. https://doi.org/10.1016/j.atherosclerosis.2016.10.017

Mohamed F, Seedat F, Raal FJ. Novel therapies for familial hypercholesterolemia. Curr Opin Endocrinol Diabetes Obes 2021; 28:188–95. https://doi.org/10.1097/MED.0000000000590

Mlinaric M, Bratanic N, Dragos V, et al. Case report: liver transplantation in homozygous familial hypercholesterolemia, long term follow up of a patient and literature review. Front Pediatr 2020;8:567895. https://doi.org/10.3389/fped.2020.567895

Ramzy D, Rao V, Brahm J, et al. Cardiac allograft vasculopathy: a review. Can J Surg 2005;48(4):319-27. PMID:16149368